Clinical Trial Update: Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis [NA]

View source ↗

Summary

A clinical trial is evaluating alternating Triamcinolone and Platelet-Rich Plasma therapy for Oral Submucous Fibrosis, and recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Submucous Fibrosis

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Karachi Medical and Dental College | Conditions: Oral Submucous Fibrosis | NA | Status: NOT_YET_RECRUITING